Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 1, 2015, Pages 195-206

  Krausz, Aimee E ^a   Adler, Brandon L ^a   Cabral, Vitor ^a   Navati, Mahantesh ^a   Doerner, Jessica ^a   Charafeddine, Rabab A ^a   Chandra, Dinesh ^a   Liang, Hongying ^a   Gunther, Leslie ^a   Clendaniel, Alicea ^b   Harper, Stacey ^b,c   Friedman, Joel M ^a   Nosanchuk, Joshua D ^a   Friedman, Adam J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c Oregon State University   (United States)

Author keywords

Antimicrobial; Burn wound; Curcumin; Infection; Nanoparticle; Wound healing

Indexed keywords

BACTERIA; NANOPARTICLES; SOLUBILITY; SYNTHESIS (CHEMICAL);

ANTIMICROBIAL; BURN WOUND; CURCUMIN; INFECTION; WOUND HEALING;

ANTIMICROBIAL AGENTS;

ANTIINFECTIVE AGENT; CURCUMIN; NANOPARTICLE; WOUND HEALING PROMOTING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BURN; BURN INFECTION; CONTROLLED STUDY; DRUG SYNTHESIS; EMBRYO; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NANOENCAPSULATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; SKIN INFECTION; SKIN INJURY; WOUND HEALING; WOUND INFECTION; ZEBRA FISH; ANIMAL; BACTERIAL INFECTIONS; BAGG ALBINO MOUSE; BURNS; CELL MOTION; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; KERATINOCYTE; LIGHT; MOUSE; NANOMEDICINE; PROCEDURES; RADIATION SCATTERING; SCANNING ELECTRON MICROSCOPY; SOLUBILITY; STEM CELL;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MURINAE; PSEUDOMONAS AERUGINOSA;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BURNS; CELL MOVEMENT; CURCUMIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; KERATINOCYTES; LIGHT; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, SCANNING; NANOMEDICINE; NANOPARTICLES; SCATTERING, RADIATION; SOLUBILITY; STEM CELLS; WOUND HEALING; ZEBRAFISH;

EID: 84919666704     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.09.004     Document Type: Article

References (50)

1. Church D., Elsayed S., Reid O., Winston B., Lindsay R. Burn wound infections. Clin Microbiol Rev 2006, 19(2):403-434.
2. de Macedo J.L., Santos J.B. Bacterial and fungal colonization of burn wounds. Mem Inst Oswaldo Cruz 2005, 100(5):535-539.
3. Vindenes H., Bjerknes R. Microbial colonization of large wounds. Burns 1995, 21(8):575-579.
4. Aziz Z., Abu S.F., Chong N.J. A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds. Burns 2012, 38(3):307-318.
5. Nguyen T.A., Friedman A.J. Curcumin: a novel treatment for skin-related disorders. J Drugs Dermatol 2013, 12(10):1131-1137.
6. Anand P., Sundaram C., Jhurani S., Kunnumakkara A.B., Aggarwal B.B. Curcumin and cancer: an "old-age" disease with an "age-old" solution. Cancer Lett 2008, 267(1):133-164.
7. Gunes H., Gulen D., Mutlu R., Gumus A., Tas T., Eren Topkaya A. Antibacterial effects of curcumin: an in vitro minimum inhibitory concentration study. Toxicol Ind Health 2013, [Epub ahead of print].
8. Sandur S.K., Ichikawa H., Pandey M.K., Kunnumakkara A.B., Sung B., Sethi G., et al. Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 2007, 43(4):568-580.
9. Somparn P., Phisalaphong C., Nakornchai S., Unchern S., Morales N.P. Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm Bull 2007, 30(1):74-78.
10. Kulac M., Aktas C., Tulubas F., Uygur R., Kanter M., Erboga M., et al. The effects of topical treatment with curcumin on burn wound healing in rats. J Mol Histol 2013, 44(1):83-90.
11. Gupta S.C., Patchva S., Aggarwal B.B. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 2013, 15(1):195-218.
12. Flora G., Gupta D., Tiwari A. Nanocurcumin: a promising therapeutic advancement over native curcumin. Crit Rev Ther Drug Carrier Syst 2013, 30(4):331-368.
13. Chereddy K.K., Coco R., Memvanga P.B., Ucakar B., des Rieux A., Vandermeulen G., et al. Combined effect of PLGA and curcumin on wound healing activity. J Control Release 2013, 171(2):208-215.
14. Bhawana, Basniwal R.K., Buttar H.S., Jain V.K., Jain N. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J Agric Food Chem 2011, 59(5):2056-2061.
15. Friedman A.J., Han G., Navati M.S., Chacko M., Gunther L., Alfieri A., et al. Sustained release nitric oxide releasing nanoparticles: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide 2008, 19(1):12-20.
16. Seleem M.N., Munusamy P., Ranjan A., Alqublan H., Pickrell G., Sriranganathan N. Silica-antibiotic hybrid nanoparticles for targeting intracellular pathogens. Antimicrob Agents Chemother 2009, 53(10):4270-4274.
17. Gupta R., Kumar A. Bioactive materials for biomedical applications using sol-gel technology. Biomed Mater 2008, 3(3):034005.
18. Yuan H., Bao X., Du Y.-Z., You J., Hu F.-Q. Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery. Int J Nanomedicine 2012, 7:5119.
19. Martinez L.R., Han G., Chacko M., Mihu M.R., Jacobson M., Gialanella P., et al. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. J Invest Dermatol 2009, 129(10):2463-2469.
20. Sanchez D.A., Schairer D., Tuckman-Vernon C., Chouake J., Kutner A., Makdisi J., et al. Amphotericin B releasing nanoparticle topical treatment of Candida spp. in the setting of a burn wound. Nanomedicine 2014, 10(1):269-277.
21. Han G., Tar M., Kuppam D.S., Friedman A., Melman A., Friedman J., et al. Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction. J Sex Med 2010, 7(1 Pt 1):224-233.
22. Nacharaju P., Tuckman-Vernon C., Maier K.E., Chouake J., Friedman A., Cabrales P., et al. A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response. Nitric Oxide 2012, 27(3):150-160.
23. Han G., Martinez L.R., Mihu M.R., Friedman A.J., Friedman J.M., Nosanchuk J.D. Nitric oxide releasing nanoparticles are therapeutic for Staphylococcus aureus abscesses in a murine model of infection. PLoS One 2009, 4(11):e7804.
24. Altman S.A., Randers L., Rao G. Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations. Biotechnol Prog 1993, 9(6):671-674.
25. Truong L., Harper S.L., Tanguay R.L. Evaluation of embryotoxicity using the zebrafish model. Methods Mol Biol 2011, 691:271-279.
26. Friedman A., Blecher K., Sanchez D., Tuckman-Vernon C., Gialanella P., Friedman J.M., et al. Susceptibility of Gram-positive and -negative bacteria to novel nitric oxide-releasing nanoparticle technology. Virulence 2011, 2(3):217-221.
27. Verallo-Rowell V.M., Dillague K.M., Syah-Tjundawan B.S. Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis. Dermatitis 2008, 19(6):308-315.
28. Wang Y., Lu Z., Wu H., Lv F. Study on the antibiotic activity of microcapsule curcumin against foodborne pathogens. Int J Food Microbiol 2009, 136(1):71-74.
29. Mohanty C., Das M., Sahoo S.K. Sustained wound healing activity of curcumin loaded oleic acid based polymeric bandage in a rat model. Mol Pharm 2012, 9(10):2801-2811.
30. Li Q., Frank M., Thisse C.I., Thisse B.V., Uitto J. Zebrafish: a model system to study heritable skin diseases. J Invest Dermatol 2011, 131(3):565-571.
31. Shehzad A., Lee Y.S. Molecular mechanisms of curcumin action: signal transduction. Biofactors 2013, 39(1):27-36.
32. Rai D., Singh J.K., Roy N., Panda D. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochem J 2008, 410(1):147-155.
33. Park B.S., Kim J.G., Kim M.R., Lee S.E., Takeoka G.R., Oh K.B., et al. Curcuma longa L. constituents inhibit sortase A and Staphylococcus aureus cell adhesion to fibronectin. J Agric Food Chem 2005, 53(23):9005-9009.
34. Rudrappa T., Bais H.P. Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models. J Agric Food Chem 2008, 56(6):1955-1962.
35. Sidhu G.S., Singh A.K., Thaloor D., Banaudha K.K., Patnaik G.K., Srimal R.C., et al. Enhancement of wound healing by curcumin in animals. Wound Repair Regen 1998, 6(2):167-177.
36. Mani H., Sidhu G.S., Kumari R., Gaddipati J.P., Seth P., Maheshwari R.K. Curcumin differentially regulates TGF-beta1, its receptors and nitric oxide synthase during impaired wound healing. Biofactors 2002, 16(1-2):29-43.
37. Gopinath D., Ahmed M.R., Gomathi K., Chitra K., Sehgal P.K., Jayakumar R. Dermal wound healing processes with curcumin incorporated collagen films. Biomaterials 2004, 25(10):1911-1917.
38. Cheppudira B., Fowler M., McGhee L., Greer A., Mares A., Petz L., et al. Curcumin: a novel therapeutic for burn pain and wound healing. Expert Opin Investig Drugs 2013, 22(10):1295-1303.
39. Topman G., Lin F.H., Gefen A. The natural medications for wound healing-curcumin, aloe-vera and ginger-do not induce a significant effect on the migration kinematics of cultured fibroblasts. J Biomech 2013, 46(1):170-174.
40. Prow T.W., Grice J.E., Lin L.L., Faye R., Butler M., Becker W., et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 2011, 63(6):470-491.
41. Samberg M.E., Oldenburg S.J., Monteiro-Riviere N.A. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspect 2010, 118(3):407-413.
42. Syng-ai C., Kumari A.L., Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther 2004, 3(9):1101-1108.
43. Anitha A., Deepagan V., Divya Rani V., Menon D., Nair S., Jayakumar R. Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate-chitosan nanoparticles. Carbohydr Polym 2011, 84(3):1158-1164.
44. Kunwar A., Barik A., Mishra B., Rathinasamy K., Pandey R., Priyadarsini K. Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells. Biochim Biophys Acta 2008, 1780(4):673-679.
45. Sanoj Rejinold N., Sreerekha P., Chennazhi K., Nair S., Jayakumar R. Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery. Int J Biol Macromol 2011, 49(2):161-172.
46. Arunraj T., Rejinold N.S., Mangalathillam S., Saroj S., Biswas R., Jayakumar R. Synthesis, characterization and biological activities of curcumin nanospheres. J Biomed Nanotechnol 2014, 10(2):238-250.
47. Kumar S.S.D., Surianarayanan M., Vijayaraghavan R., Mandal A.B., MacFarlane D. Curcumin loaded poly (2-hydroxyethyl methacrylate) nanoparticles from gelled ionic liquid-in vitro cytotoxicity and anti-cancer activity in SKOV-3 cells. Eur J Pharm Sci 2014, 51:34-44.
48. Rizzo L.Y., Golombek S.K., Mertens M.E., Pan Y., Laaf D., Broda J., et al. In vivo nanotoxicity testing using the zebrafish embryo assay. J Mater Chem B Mater Biol Med 2013, 1(32):3918-3925.
49. Strahle U., Scholz S., Geisler R., Greiner P., Hollert H., Rastegar S., et al. Zebrafish embryos as an alternative to animal experiments-a commentary on the definition of the onset of protected life stages in animal welfare regulations. Reprod Toxicol 2012, 33(2):128-132.
50. Irmler I., Schmidt K., Starck J.M. Developmental variability during early embryonic development of zebra fish, Danio rerio. J Exp Zool B Mol Dev Evol 2004, 302(5):446-457.